
DoseMap: GLP-1 & Peptide
Private GLP-1 peptide tracker
About
What's New in DoseMap
DoseMap includes app review or production readiness improvements
July 23, 2026
What to test: Test the full app flow including onboarding, account sign-in, Google Sign-In, premium paywall, schedule tracking, dose logs, body metrics, inventory, low-stock alerts, insights, CSV/PDF export, and settings. What’s new: Added Firebase Google Sign-In, improved account sign-in flow, fixed paywall header layout on smaller iPhones, improved premium screen spacing, connected signed-in users with subscription identity, and included recent tracker updates for body metrics, richer check-ins, inventory tracking, low-stock alerts, progress insights, and CSV/PDF exports.
MoreSubscriptions & In-App Purchases
DoseMap Premium Weekly
Unlock DoseMap Premium weekly.



